Fairmark Partners is investigating the possibility of filing a class-action lawsuit, along with help from current and former employees, against aerospace giant Lockheed Martin over its handling of employee benefit contributions.

Instead of jumping to GLP-1 drugs that can be costly, a step therapy approach guides patients by offering individualized care with behavioral changes, followed by mental health support and Gen 1 anti-obesity meds.

Sens. Elizabeth Warren and Mike Braun wrote a letter to HHS last week to investigate high drug prices – and any role played by health insurers' shared ownership with the pharmacies that often fill the prescriptions.

The American Medical Association passed a resolution supporting coverage for "evidence-based treatment of obesity, including FDA-approved medications without exclusions," which puts pressure on insurers and employers.

One in five said they already have gotten the new vaccine that became available in September, with an additional 28% saying they definitely or probably will do so.

The average employed person with diabetes misses nearly 5.5 days of work each year because of illness, which translates to roughly $650 in lost wages.

The annual contribution limit for flexible spending accounts will rise to $3,200 in 2024, an increase of $150 from this year, the IRS recently announced.

As CEO of Cost Plus Drug Co., Mark Cuban is telling other CEOs: "If the big 3 PBMs, which also own the insurance companies, lose 5 of the top 15 non-PBM Fortune 50 companies, their business practices are going to change."